ZyVersa Therapeutics Balans Gezondheid
Financiële gezondheid criteriumcontroles 4/6
ZyVersa Therapeutics has a total shareholder equity of $8.6M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $19.5M and $10.8M respectively.
Belangrijke informatie
0%
Verhouding schuld/eigen vermogen
US$0
Schuld
Rente dekkingsratio | n/a |
Contant | US$119.49k |
Aandelen | US$8.62m |
Totaal verplichtingen | US$10.85m |
Totaal activa | US$19.47m |
Recente financiële gezondheidsupdates
Recent updates
Analyse van de financiële positie
Kortlopende schulden: ZVSA's short term assets ($641.4K) do not cover its short term liabilities ($10.0M).
Langlopende schulden: ZVSA's short term assets ($641.4K) do not cover its long term liabilities ($854.6K).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: ZVSA is debt free.
Schuld verminderen: ZVSA had no debt 5 years ago.
Balans
Analyse van de cashflow
Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.
Stabiele cash runway: ZVSA has sufficient cash runway for 0 months based on last reported free cash flow, but has since raised additional capital.
Voorspelling contante baan: ZVSA is forecast to have sufficient cash runway for 0 months based on free cash flow estimates, but has since raised additional capital.